Q4 2019 Q Linea AB Earnings Call Transcript
Thank you very much. With that, I'd like to welcome everyone to the fourth quarter report for Q Linea during 2019. We'll move through the presentation, and we look at slide number 2, which is our disclaimer slide in case we do any forward-looking statements.
If we then move into slide number 3, that's going to give a brief overview of Q Linea, in general. We are a company working with disruptive solutions for faster infectious disease diagnostics. The first product, as you can see, to right, it's ASTar instrument followed by consumables with a first focus on sepsis. I would also like to highlight on this Q4 call, we had a very important event after the end of the period that was announced late last night. That we have and now a global partnership with Thermo Fisher Scientific for the commercialization of ASTar. And I will come back to that at the end of my presentation. But I want to highlight that as a very key event in the company development.
If we then look at the company as such, we are located in Uppsala, Sweden, we have the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |